Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis
Clinical trial NCT02618759 · COMPLETED
Trial details
- NCT number
- NCT02618759
- Sponsor
- Sun Pharmaceutical Industries, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-28
- Primary completion
- 2017-03-16
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.